Jeffrey F Eisenberg's Net Worth
$1.87 Million
Who is Jeffrey F Eisenberg?
Jeffrey F Eisenberg has an estimated net worth of $1.87 Million. This is based on reported shares across multiple companies, which include Xenetic Biosciences, Inc., MABVAX THERAPEUTICS HOLDINGS, INC., and NOVEN PHARMACEUTICALS INC.
SEC CIK
Jeffrey F Eisenberg's CIK is 0001224096
Past Insider Trading and Trends
2006 was Jeffrey F Eisenberg's most active year for acquiring shares with 10 total transactions. Jeffrey F Eisenberg's most active month to acquire stocks was the month of November. 2006 was Jeffrey F Eisenberg's most active year for disposing of shares, totalling 34 transactions. Jeffrey F Eisenberg's most active month to dispose stocks was the month of August. 2006 saw Jeffrey F Eisenberg paying a total of $1,078,126.00 for 122,127 shares, this is the most they've acquired in one year. In 2006 Jeffrey F Eisenberg cashed out on 194,261 shares for a total of $2,204,655.19, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Xenetic Biosciences, Inc. (XBIO) Snapshot price: $4.09
Chief Executive OfficerJeffrey F Eisenberg owns 50,000 units of Common Stock which is worth $204,500.00. In the year 2016 Jeffrey F Eisenberg filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MABVAX THERAPEUTICS HOLDINGS, INC. No price found
InvestorJeffrey F Eisenberg owns 64,558 units of Common Stock. From 2016 to 2018 Jeffrey F Eisenberg acquired a total of 100,000 shares in MABVAX THERAPEUTICS HOLDINGS, INC., Jeffrey also disposed a total of 35,442 shares of MABVAX THERAPEUTICS HOLDINGS, INC. equalling to $30,294.60.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -35.44% | -35.44K |
$0.85 | -$30,294.60 | 64.56K |
Jan 23 - Jan 24
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVEN PHARMACEUTICALS INC No price found
Executive Vice PresidentJeffrey F Eisenberg used to own units in Common Stock ($.0001 par value) but no longer holds any shares there.acquired a total of 124,243 shares in NOVEN PHARMACEUTICALS INC at a cost of $1,181,212.11, Jeffrey also disposed a total of 125,493 shares of NOVEN PHARMACEUTICALS INC equalling to $2,814,946.99.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.83K |
$16.50 | -$30,277.50 |
0
|
Aug 27
| |||
Form 4
| -86.59% | -11.85K |
$16.50 | -$195,459.00 | 1.83K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
| +115.82% | 7.34K |
—
|
—
| 13.68K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
$20.45 | -$13,235.69 | 6.34K |
Scheduled
|
Feb 7
| ||
Form 4
|
—
|
0
|
$17.92 | -$179,395.70 | 24.88K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
$19.45 | -$126,900.00 | 6.34K |
Scheduled
|
Oct 26
| ||
Form 4
|
—
|
0
|
$18.95 | -$86,739.80 | 6.34K |
Scheduled
|
Oct 10
| ||
Form 4
|
—
|
0
|
$18.95 | -$30,160.20 | 6.34K |
Scheduled
|
Sep 29
| ||
Form 4
|
—
|
0
|
$17.74 | -$442,481.90 | 6.34K |
Scheduled
|
Sep 11
| ||
Form 4
| +86.44% | 2.94K |
$14.80 | $3.81 | 6.34K |
Aug 9
| |||
Form 4
|
—
|
0
|
$15.00 | -$180,000.00 | 3.4K |
Scheduled
|
Jul 25
| ||
Form 4
|
—
|
0
|
$13.07 | -$80,855.40 | 3.4K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
| +172.00% | 2.15K |
$14.41 | -$268,233.50 | 3.4K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
| No matching records found | |||||||||